What's new? Log in Free sign up

Filing search / Kineta, Inc. / "Community"

Search information

Kineta, Inc.

Companies

"Community"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

81 results

Newest first Best match first

KANT Kineta, Inc.

Kineta and TuHURA are collaborating on the ongoing Phase 1/Phase 2 clinical trial in patients with advance solid tumor cancer

community. VISTA expression is broadly observed in patients with a number of solid and hematologic cancers. KVA12123 may provide a valuable therapeutic

KANT Kineta, Inc.

Definitive proxy

by a footnote, and subject to community property laws where applicable, we believe based on the information provided to us that the persons and entities named

26 Apr 24

4:00pm

KANT Kineta, Inc.

and marketing organization in the United States to sell its products. Kineta believes that such an organization will be able to address the community … a Marketing Authorization (“MA”). There are two types of marketing authorizations: the Community MA, which is issued by the European Commission

21 Mar 24

4:06pm

KANT Kineta, Inc.

Definitive proxy

power with respect to securities. Except as noted by a footnote, and subject to community property laws where applicable, we believe based

28 Apr 23

5:09pm

KANT Kineta, Inc.

the community of oncologists who are the key specialists in treating cancer patients for which its product candidates are being developed. Competition … : the Community MA, which is issued by the European Commission through the Centralized Procedure, based on the opinion of the Committee for Medicinal Products

31 Mar 23

4:05pm

Kineta Completes Reverse Merger with Yumanity Therapeutics

Kineta Completes Reverse Merger with Yumanity Therapeutics

Quarterly report

14 Nov 22

8:44am

Prospectus supplement

Registration of securities issued in business combination transactions (amended)

4 Nov 22

4:49pm

Registration of securities issued in business combination transactions (amended)

24 Oct 22

9:14am

xvyoovq377ws01dzne2

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

1wi76zuyorgqh69ppug

Registration of securities issued in business combination transactions

29 Aug 22

12:00am

3ux s71s004kfchkokdr

Registration of securities issued in business combination transactions

29 Aug 22

12:00am

7b4cvpcn96vwgg87o0mu

Registration of securities issued in business combination transactions

29 Aug 22

12:00am

Quarterly report

4 Aug 22

5:12pm

Business combination disclosure

w32vdo8aei0p6op 9dr

Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions

Prev
1
2
3
4
5
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.